Search

Your search keyword '"Waubant, E."' showing total 574 results

Search Constraints

Start Over You searched for: Author "Waubant, E." Remove constraint Author: "Waubant, E."
574 results on '"Waubant, E."'

Search Results

1. Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.

2. Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS

3. Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population.

4. Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial

5. Precision medicine in chronic disease management: The multiple sclerosis BioScreen

6. Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network

7. Spinal cord gray matter atrophy correlates with multiple sclerosis disability

8. Copy number variation in pediatric multiple sclerosis

9. Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures

11. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis

14. Myelin-oligodendrocyte glycoprotein antibody-associated disease

15. The onset location of multiple sclerosis predicts the location of subsequent relapses

16. Predictors of the location of multiple sclerosis relapse

17. Aggressive multiple sclerosis (2): Treatment

18. Aggressive multiple sclerosis (1) : Towards a definition of the phenotype

23. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

24. Clinical trials of disease-modifying agents in pediatric MS Opportunities, challenges, and recommendations from the IPMSSG

27. Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis

29. The challenge of comorbidity in clinical trials for multiple sclerosis

30. Gender Inequities in the Multiple Sclerosis Community: A Call for Action

32. Acute Flaccid Paralysis with Anterior Myelitis — California, June 2012–June 2014

35. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures

36. Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population

37. Defining the clinical course of multiple sclerosis: the 2013 revisions.Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28

39. Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder

40. REPLAY Study Group. Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study.J Child Neurol. 2013 Jul;28(7):849-56. doi: 10.1177/0883073813488828. Epub 2013 May 10

41. Treatment of Neuromyelitis Optica: Review and Recommendations

42. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

43. Randomized controlled trial of atorvastatin in clinically isolated syndrome: The STAyCIS study

46. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

47. A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking

49. The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL

Catalog

Books, media, physical & digital resources